1 Min Read
Aug 5 (Reuters) - Aequus Pharmaceuticals Inc
* Aequus announces advancement of Anti-Nausea Transdermal Extended-Release patent application Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.